What if seniors who enrolled in Medicare’s Part D prescription benefit were allowed to participate in the same prescription drug rebates that PBMs negotiate on behalf of insurers? In an effort to make good on his campaign promise to lower prescription drug prices,...
The National Association of Specialty Pharmacy (NASP) made a bold and decisive move by stating its position on specialty drug pricing’s two most controversial issues – DIR Fees and PBM Complicity. The NASP believes that the lack of transparency in assessing these fees...
